Jaglowski, S. M., Ruppert, A. S., Hofmeister, C. C., Elder, P., Blum, W., Klisovic, R., . . . Andritsos, L. A. (2014). The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma.
Citação norma ChicagoJaglowski, Samantha M., et al. The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma. 2014.
Citação norma MLAJaglowski, Samantha M., et al. The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma. 2014.